Talecris Biotherapeutics Release: New Pediatrician Education Program Launched To Increase Awareness And Improve Diagnosis Of Immunodeficiencies In Children

ELK GROVE VILLAGE, Ill., NEW YORK & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The American Academy of Pediatrics (AAP), the Jeffrey Modell Foundation (JMF), and Talecris Biotherapeutics (Talecris) jointly announced today the launch of a new continuing medical education program to increase awareness and speed diagnosis of primary immune deficiencies in children. The program, entitled “Immunodeficiency in Pediatrics,” is supported through grants from JMF and Talecris, and is available in CD-ROM format as Volume 1, Issue 10 of AAP’s innovative PREP® Audio continuing medical education (CME) series. The grants provided by Talecris and JMF allow the “Immunodeficiency in Pediatrics” program to be made available for free to approximately 35,000 subscribers of Pediatrics in Review. The CD-ROM is provided as part of an ad for the larger PREP® Audio series in the October issue.
MORE ON THIS TOPIC